Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: A 5.5-year retrospective cohort study

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Chalermchockcharoenkit, Amphan ^a   Chayachinda, Chenchit ^a   Thamkhantho, Manopchai ^a   Komoltri, Chulaluk ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELL CANNOT EXCLUDE HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CANCER INCIDENCE; CD4 LYMPHOCYTE COUNT; CONTRACEPTION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; THAILAND; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; AIDS RELATED COMPLEX; CYTOLOGY; EARLY DIAGNOSIS; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MIDDLE AGED; PATHOLOGY; PREGNANCY; RETROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HIV; HUMANS; INCIDENCE; MIDDLE AGED; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 78650948539     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-8     Document Type: Article

References (29)

1. Epidemiological Fact Sheet on HIV and AIDS: Core data on epidemiology and response; Thailand 2008 update. , http://www.who.int/hiv/pub/epidemiology/pubfacts/en/
2. Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S. Malignancies in HIV-infected Thai patients. HIV Med 2007, 8(5):322-3. 10.1111/j.1468-1293.2007.00471.x, 17561879.
3. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283(8):1031-7. 10.1001/jama.283.8.1031, 10697063.
4. Chalermchockcharoenkit A, Sirimai K, Chaisilwattana P. High prevalence of cervical squamous cell abnormalities among HIV-infected women with immunological AIDS-defining illnesses. J Obstet Gynaecol Res 2006, 32(3):324-9. 10.1111/j.1447-0756.2006.00411.x, 16764624.
5. Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999, 180(4):824-36. 10.1016/S0002-9378(99)70653-8, 10203650.
6. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994, 84(4):591-7.
7. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, Minkoff H. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998, 68(3):233-9. 10.1006/gyno.1998.4938, 9570972.
8. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Buren D, Greenblatt RM, Muderspach LI, Miotti P. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999, 21(1):33-41.
9. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002, 288(14):1749-57. 10.1001/jama.288.14.1749, 12365959.
10. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000, 9(9):945-51.
11. Schneider A, Hoyer H, Lotz B, Leistritza S, Kuhne-Heid R, Nindl I, Muller B, Haerting J, Durst M. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000, 89(6):529-34. 10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G, 11102899.
12. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000, 132(10):810-9.
13. CDC Guidelines for preventing opportunistic infections among HIV-infected persons-2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Socciety of America. WWMR Recomm Rep 2002, 5(RR-8):1-52. CDC.
14. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Shueman M, Wilbur D, Wright T, Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287(16):2114-9. 10.1001/jama.287.16.2114, 11966386.
15. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002, 287(16):2120-9. 10.1001/jama.287.16.2120, 11966387.
16. Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A. Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis 2006, 42(4):562-8. 10.1086/499357, 16421802.
17. Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005, 293(12):1471-6. 10.1001/jama.293.12.1471, 15784870.
18. Agaba PA, Thacher TD, Ekwempu CC, Idoko JA. Cervical dysplasia in Nigerian women infected with HIV. Int J Gynaecol Obstet 2009, 107(2):99-102. 10.1016/j.ijgo.2009.06.006, 19619874.
19. Micheletti AM, Dutra Vde F, Murta EF, Paschoini MC, Silva-Vergara ML, Barbosa e Silva G, Adad SJ. Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load. Diagn Cytopathol 2009, 37(3):164-9. 10.1002/dc.20892, 19170167.
20. Franceschi S, Dal Maso L, Suligoi B, Rezza G. Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev 2006, 15(6):554-6. 10.1097/01.cej.0000220640.69341.59, 17106339.
21. Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Virapat P, Tunthanathip P, Ausavapipit J, Lokpichat S, Siangphoe U, Jirarojwat N, Pobkeeree V, Supawitkul S, Tappero JW, Levine WC. Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project. Sex Transm Dis 2007, 34(2):104-7. 10.1097/01.olq.0000222716.17186.9f, 16755274.
22. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008, 17(6):545-54. 10.1097/CEJ.0b013e3282f75ea1, 18941376.
23. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Journal of the National Cancer Institute 2004, 96(14):1070-6. 10.1093/jnci/djh192, 15265968.
24. Levi JE, Fink MC, Canto CL, Carretiero N, Matsubara R, Linhares I, Das Dores GB, Castelo A, Segurado A, Uip DE, Eluf JJ. Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis 2002, 6(3):129-35. 10.1590/S1413-86702002000300005, 12144749.
25. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute 1999, 91(3):226-36. 10.1093/jnci/91.3.226, 10037100.
26. Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, Moore C, Heard I, Agarossi A, Casolati E, Denny L, Bradbeer C, Lyons F, Beattie G, Niemiec T. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer 2007, 121(11):2484-91. 10.1002/ijc.22947, 17683070.
27. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 2000, 85(2):206-10.
28. Holcomb K, Abulafia O, Matthews RP, Chapman JE, Borges A, Lee YC, Buhl A. The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol 1999, 75(1):118-21. 10.1006/gyno.1999.5554, 10502437.
29. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 2004, 4(1):46-54. 10.1038/nri1260, 14704767.